EIF3C and non-small cell lung carcinoma: To make clear the clinical importance of eIF3c in the resistance to EGFR-TKI, we performed eIF3c immunohistochemistry analysis on 27 lung tumor biopsy samples from EGFR-sensitizing mutant NSCLC patients.